when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Diagnostics Company · news · pharmadog

← back to Diagnostics Company

News · Diagnostics Company

94 stories

Jul 27, 26Labcorp launches DTC ‘Genetic Health Panel’ to seek out multiple diseasesfiercebiotech

Jul 23, 26STAT+: HHS to convene experts on standards for clinical AIstat

Jul 23, 26Roche's late stage pipeline 'so full,' CEO Schinecker not feeling pressure to add onbiospace

Jul 23, 26Roche Diagnostics growth remains muted amid China headwindsfiercebiotech

Jul 21, 26Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial rolefiercebiotech

Jul 21, 26Recon: Novo sues Lilly over weight-loss drug ads; Gilead, Merck say HIV pill keeps HIV suppressed in two Phase 3 trialsraps

Jul 20, 26Tempus to acquire cancer test maker Personalis for $1.5Bbiopharma dive

Jul 20, 26Tempus to buy cancer test-maker Personalis for $1.5Bbiopharma dive

Jul 20, 26Tempus buys out cancer genomics partner Personalis in $1.5 billion dealfiercebiotech

Jul 20, 26BMS expands AI footprint with Nvidia, aiming for ‘most powerful AI factory in life sciences’fiercebiotech

Jul 19, 26Abbott hit by cyberattack on cancer diagnostics, LabCentral portal businessesfiercebiotech

Jul 17, 26Abbott Q2 led by strong device, diagnostic sales as it boosts profit forecastfiercebiotech

Jul 16, 26STAT+: Medicare wants to shake up how it pays for clinical AIstat

Jul 15, 26STAT+: New study untangles how Epstein-Barr viral infection triggers immune response in multiple sclerosisstat

Jul 15, 26STAT+: Improvements in Alzheimer’s testing could make diagnostics more accessible, informativestat

Jul 13, 26Opinion: Is there a doctor on board? Yes, and airlines depend on itstat

Jul 12, 26STAT+: Tau in the spotlight at Alzheimer’s conferencestat

Jul 6, 26Opinion: Stopping doctors from ordering unnecessary diagnostic tests requires a structural fixstat

Jul 1, 26Opinion: What Ebola and Marburg are teaching us about the next pandemicstat

Jun 26, 26FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences servicesbiopharma dive

Jun 18, 26Opinion: AI’s growing appetite for power is a public health issue. Here’s a fixstat

Jun 16, 26Neumora depression drug fails; EnGene to cut 50% of staffbiopharma dive

Jun 16, 26Opinion: I’m an Alzheimer’s specialist. I still missed it in my own fatherstat

Jun 13, 26Opinion: ‘I’m pretty much all in’: An interview with a woman starting medical residency at almost 73stat

Jun 8, 26Precision under pressure: Logistic solutions for nuclear medicine scalabilitybiopharma dive

Jun 3, 26STAT+: NIH cuts weakened network primed to respond to outbreaks like Ebolastat

Jun 2, 26Why US-manufactured pharmaceutical packaging equipment mattersbiopharma dive

May 17, 26When should you get a mammogram? Conflicting advice makes it hard to knowstat

May 8, 26STAT+: Roche to buy PathAI for $750 millionstat

May 7, 26Roche to acquire digital pathology firm PathAI in deal potentially worth over $1Bbiopharma dive

← prevpage 3 of 4next →